Business Wire

Twenty-Five Year Political Veteran Sam Myers, Jr. Named President of Direct Impact

24.9.2019 19:52:00 EEST | Business Wire | Press release

Share

BCW (Burson Cohn & Wolfe), a leading global communications agency, today announced that Sam Myers, Jr., has been named President of Direct Impact (DI), the nation's leading grassroots campaign firm and member of BCW Group. Myers is based in Washington, D.C., and is charged with building DI’s industry-leading work in developing local market campaigns that drive communities to take action around various public affairs, public education and corporate reputation issues.

“I am thrilled that Sam will be leading DI,” said Chris Foster, President of BCW North America. “His more than two decades of political campaign experience and having served at the highest levels of government will be invaluable to clients that are navigating increasingly complex communications and legislative environments.”

Myers has served in two presidential administrations and worked on six presidential campaigns. From 2009 to 2017 he served in the Obama administration, in multiple leadership roles. For the U.S. Department of Education, his efforts in the Office of the Secretary and as head of Office of the White House Liaison helped put in place policies that supported narrowing the skills gap, job creation, healthy eating in schools and America’s College Promise.

Myers also spearheaded change management and communication for Department of Commerce’s move to a department-wide, enterprise services model. For the White House, he led delegations to the Vatican, UN General Assembly and Aspen Ideas Festival. In the Clinton administration, he served as an advance staffer for President Clinton and as a Defense Fellow at the U.S. Department of Defense.

Upon leaving the public sector in 2017, Myers transitioned to Brooklyn-based Huge, Inc., working in a series of roles, most recently Vice President for Partnerships and Development, where he developed thought leadership platforms around autonomous vehicles, aerospace, maternal health and the future of work; created partnerships at SXSW, CES and Cannes, among others; and drove strategic growth for Huge’s Washington, D.C. office and global business. He then served as a Senior Vice President for San Francisco-based The OutCast Agency, charged with expanding the agency’s Washington, D.C. presence.

“Across my 25 years in campaigns, politics and public affairs, the one constant I have seen is how powerful it is when companies and organizations connect with people on their own turf about the issues they care about the most,” said Myers. “I have watched and marveled at the extraordinary work DI has done in this area and I jumped at the chance to lead this great team.”

Myers’ campaign experience includes working on Hillary for America 2016; Obama for America; John Edwards for President 2008; Kerry Edwards 2004; Gore/Lieberman 2000; Clinton/Gore 1996 and founding DC based Myers Strategies in 2004, focused on effective messaging through national grass roots events.

About Direct Impact

Founded in 1988, Direct Impact (DI) is a wholly owned subsidiary of BCW and a member of the WPP family. DI is a premier grassroots communications firm, specializing in public affairs, public education and corporate reputation campaigns. DI provides a complete range of services essential to conducting successful localized campaigns, focusing on legislative battles as well as corporate branding challenges across the country. DI has led winning, community-driven campaigns for more than half of the Fortune 50, as well as major trade associations and coalitions.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media: Catherine Sullivan
Phone: 212.601.3205
Email: Catherine.Sullivan@bcw-global.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release

Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye